Showing results (141-150 of 651) with videos related to
Sort By:
Pageof 66
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2020
Invasive Mycobacterium abscessus Complex Infection After Cardiac Surgery: Epidemiology, Management, and Clinical OutcomesArthur W Baker, Eileen K Maziarz, Sarah S Lewis, et al.American Journal of Infection Control|October 27, 2023
..úNo touch..Ñ methods for health care room disinfection: Focus on clinical trialsDavid J Weber, William A Rutala, Deverick J Anderson, et al.Nature Communications|September 27, 2024
Private benefit of β-lactamase dictates selection dynamics of combination antibiotic treatmentHelena R Ma, Helen Z Xu, Kyeri Kim, et al.Infectious Disease Clinics of North America|February 27, 2026
Blueprint for a Successful Infection Prevention ProgramSorabh Dhar, Amanda Valyko, Keith S Kaye, et al.Antimicrobial Agents and Chemotherapy|December 24, 2008
Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infectionsRonald P Olson, Lizzie J Harrell, Keith S KayeInternational Journal of Antimicrobial Agents|February 4, 2019
Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experienceChristopher J Destache, David J Guervil, Keith S KayeVirulence|July 8, 2016
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant EnterobacteriaceaeJoshua T Thaden, Jason M Pogue, Keith S KayeInternational Journal of Antimicrobial Agents|November 24, 2016
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?Jason M Pogue, Jessica K Ortwine, Keith S KayeInfectious Disease Clinics of North America|December 15, 2019
Collaborative Antimicrobial Stewardship: Working with Hospital and Health System AdministrationWhitney R Buckel, Keith S Kaye, Payal K PatelClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2018
Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary ConsiderationsJason M Pogue, Robert A Bonomo, Keith S KayePageof 66